Drugs / Vigam®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02247154 | Apr 1999 → Jul 2001 | immunodeficiency disease | Bio Products Laboratory | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vigam | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02247154 ↗ |
| Known as | Human Normal Immunoglobulin | “Vigam® (Human Normal Immunoglobulin)” NCT02247154 ↗ |
| Modality | Protein / enzyme biologic | “Human Normal Immunoglobulin” NCT02247154 ↗ |
| Route | Intravenous | “Intravenous Immunoglobulin” NCT02247154 ↗ |